Latisse

Latisse (bimatoprost ophthalmic 0.03%) is administered by applying it nightly to the skin of the upper eyelid margin at the base of the eyelashes using an applicator. Any excess Latisse ® solution should be blotted away and the Latisse ® applicator is only meant to be used one time

Latisse side effects do exist. Side effects of Latisse (bimatoprost ophthalmic solution) include iris pigmentation, lowering of intraocular (eye) pressure, hair growth outside of the treatment area, contact lens discoloration, and infection if the applicator is contaminated. Other side effects of Latisse ® use include itching, skin changes, dry eye and other eye disorders. Like most medications, Latisse ® can cause an allergic reaction in susceptible people. Latisse (bimatoprost ophthalmic) should not be used by people who are hypersensitive to the medication. Questions regarding the use and safety of Latisse ® should be directed to one’s medical provider and pharmacist.

Latisse ® is not inexpensive. One 5 mL bottle of Latisse 0.03% will cost approximately $62 at many pharmacies in the United States. Latisse ® coupons may also be available through the manufacturer and a generic Latisse ® version was released by Sandoz in 2016. Most insurance plans will not cover the cost of Latisse as it is typically considered an elective medication. Once administered, bimatoprost is primarily found in the plasma and a minority of it is not bound to proteins. Bimatoprost demonstrates a half life as short as 45 minutes and the majority of the drug is excreted in the urine. Farmington Drugs & Medical Supplies takes pride in offering the most cost efficient services and prescriptions to our patients.

Latisse ® is a medication that contains the active ingredient bimatoprost ophthalmic solution 0.03% and is a synthetic prostaglandin analog. Latisse ® was approved by the FDA to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness and darkness. Latisse ® is thought to work by increasing the percent of hairs in and the duration of the growth phase. After one drop of bimatoprost ophthalmic solution, blood levels have been demonstrated to peak within ten minutes and were below detection levels within 1.5 hours after dosing.

• Click here for FDA information

Given the evolving nature of medicine and science, this information might not be accurate and should not be construed as medical advice or diagnosis / treatment recommendations. Please consult a licensed medical provider if you have additional questions.